Torrent Pharmaceuticals Share Price
4868.00-37.50 (-0.76%)
+34.97% past 1 Year
Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations. The company is a leading player in the areas of Cardiovascular and Central Nervous Systems, having achieved
Corporate filings & documents
Announcements
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
3 weeks agoIntimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
3 weeks agoESG Rating
3 weeks agoESG Rating
3 weeks agoNewspaper Advertisement for completion of dispatch of Postal Ballot Notice
4 weeks agoNewspaper Advertisement for completion of dispatch of Postal Ballot Notice
4 weeks agoNotice of Postal Ballot
4 weeks agoNotice of Postal Ballot
4 weeks agoTranscript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June 2026
1 month agoTranscript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June 2026
1 month agoIntimation of Cessation of Director of the Company
1 month agoIntimation of Cessation of Director of the Company
1 month agoRecording Link of Analyst call - Q1 Results
1 month agoRecording Link of Analyst call - Q1 Results
1 month agoChange in Senior Management Personnel
1 month agoChange in Senior Management Personnel
1 month agoOutcome of Board Meeting dated 30-Jul-26
1 month agoOutcome of Board Meeting dated 30-Jul-26
1 month agoResults for quarter ended 30-Jun-26
1 month agoResults for quarter ended 30-Jun-26
1 month agoAppointment of Shanti Ekambaram as an Independent Director of the Company
1 month agoAppointment of Shanti Ekambaram as an Independent Director of the Company
1 month agoReceipt of final listing and Trading approval for Equity shares of the Company issued and allotted in terms of Scheme of Amalgamation
1 month agoReceipt of final listing and Trading approval for Equity shares of the Company issued and allotted in terms of Scheme of Amalgamation
1 month agoAllotment of Equity shares of the Company to eligible shareholders of J B Chemicals as on Record Date in terms of Scheme of Amalgamation
1 month agoAllotment of Equity shares of the Company to eligible shareholders of J B Chemicals as on Record Date in terms of Scheme of Amalgamation
1 month agoDisclosure pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 - Dissolution of Wholly Owned Subsidiary (WOS)
1 month agoDisclosure pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 - Dissolution of Wholly Owned Subsidiary (WOS)
1 month agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015 - ESG Rating
1 month agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015 - ESG Rating
1 month agoPost Quarterly Financial Result Conference call with investors / analyst
1 month agoPost Quarterly Financial Result Conference call with investors / analyst
1 month agoTorrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 inter alia to consider and approve to consider and approve the Unaudited Standalone and Consolidated Financial Results (with limited review) for the quarter ended on 30-Jun-26.
1 month agoTorrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 inter alia to consider and approve to consider and approve the Unaudited Standalone and Consolidated Financial Results (with limited review) for the quarter ended on 30-Jun-26.
1 month agoPress Release
1 month agoPress Release
1 month agoNewspaper advertisement in respect of special window for transfer and dematerialisation request of physical shares
1 month agoNewspaper advertisement in respect of special window for transfer and dematerialisation request of physical shares
1 month agoAmendment to Memorandum of Association
1 month agoAmendment to Memorandum of Association
1 month agoIntimation of Effective Date of Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders
1 month agoIntimation of Effective Date of Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders
1 month agoRecord date in the matter of Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders
1 month agoRecord date in the matter of Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders
1 month agoReceipt of Certified copy of final order from the Honble NCLT Ahmedabad Bench sanctioning Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders
1 month agoReceipt of Certified copy of final order from the Honble NCLT Ahmedabad Bench sanctioning Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders
1 month agoPronouncement of final order by the Honble National Company Law Tribunal Ahmedabad Bench sanctioning the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders
1 month agoPronouncement of final order by the Honble National Company Law Tribunal Ahmedabad Bench sanctioning the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders
1 month agoIntimation of the Closure of Trading Window as per Companys Code of Conduct to Regulate Monitor and Report Trading by Designated Persons
2 months agoIntimation of the Closure of Trading Window as per Companys Code of Conduct to Regulate Monitor and Report Trading by Designated Persons
2 months agoConcalls & investor presentations
Jul 2026
ConcallPresentation
May 2026
Feb 2026
Nov 2025
ConcallPresentation
Jul 2025
May 2025
Jan 2025
Oct 2024
Jul 2024
May 2024
Feb 2024
Oct 2023
Aug 2023
May 2023
Jan 2023
Oct 2022
Jul 2022
May 2022
Jan 2022
ConcallPresentation
Oct 2021
Jul 2021
May 2021
Feb 2021
Oct 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-05-29
Dividend
9.0
2026-02-18
Dividend
29.0
2025-06-20
Dividend
6.0
2025-01-31
Dividend
26.0
2024-06-21
Dividend
6.0
2024-02-12
Dividend
22.0
2023-06-23
Dividend
8.0
2023-02-03
Dividend
14.0
2022-07-08
Bonus
1:1
2022-02-02
Dividend
25.0
2021-06-17
Dividend
15.0
2021-02-15
Dividend
20.0
2020-03-18
Dividend
32.0
2019-06-13
Dividend
4.0
2019-02-06
Dividend
13.0
2018-06-18
Dividend
5.0
2018-02-15
Dividend
9.0
2017-06-19
Dividend
4.0
2017-02-10
Dividend
10.0
2016-03-16
Dividend
15.0
2016-02-11
Dividend
20.0
2015-06-15
Dividend
6.25
2015-02-02
Dividend
5.0
2014-06-16
Dividend
5.0
2014-01-24
Dividend
5.0
2013-07-23
Bonus
1:1
2013-06-10
Dividend
17.0
2013-02-01
Dividend
6.0
2012-06-11
Dividend
2.5
2012-01-27
Dividend
6.0
2011-06-06
Dividend
8.0
2010-06-04
Dividend
6.0
Company details
Registered office
Avirat Thaltej Shilaj Road Ahmedabad Gujarat PIN: 380059 Tel No: 079-26599000 Fax No: 079-26582100 Email: [email protected] Internet: www.torrentpharma.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Samir Mehta, Chairman
Nayantara Bali, Non Executive Independent Director
Manish Choksi, Non Executive Independent Director
Nikhil Khattau, Non Executive Independent Director
Aman Mehta, Managing Director
Jinal Mehta, Non Independent & Non Executive Director
Chintan Trivedi, Company Secretary & Compliance Officer
Details
BSE 500420
NSE TORNTPHARM
ISIN INE685A01028